CIRCLE8 Group Inc. CIRC
Biotechnology: Laboratory Analytical Instruments · IPO 2024 · data as of November 13, 2026
CIRCLE8 Group Inc. (CIRC) is a industrial company listed in the US with a market value of about $22M. In the twelve months to June 30, 2026 it had revenue of $800M and net income of -$155M, a net margin of -19.4%.
Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (2/5); the weakest is financial health (0/5).
Key numbers: 5-year revenue growth of 321% a year, a 5-year average ROIC of -31%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 3311% above the current price.
About CIRCLE8 Group
CIRCLE8 Group is listed in the US and classified in biotechnology: laboratory analytical instruments, IPO year 2024. Revenue went from $329495 in 2020 to $436M in 2025, growth of about 321.0% a year. It was profitable in 0 of the last 6 years in our data. Its share count rose by 144% over three years (dilution for shareholders).
Score: 1.2 / 5
Checks passed
- Price below intrinsic value (DCF, moderate assumptions)
- 3-year revenue growth above 10% a year
- Profit margin improving
- 5-year revenue growth above 8% a year
- ROE above 15%
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
Valuation
Growth and quality
Financials, last 6 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $800M | $436M | $443M | $401M | $78659 | $209995 | $329495 |
| Net income | -$155M | -$59M | -$135M | -$15M | -$4M | -$4M | -$1M |
| Free cash flow | -$23M | -$4M | -$6M | -$9M | -$4M | -$2M | — |
| EPS (diluted) | $-2.11 | $-1.08 | $-3.68 | $-0.60 | $-0.18 | $-0.27 | $-0.11 |
| Net margin | -19.4% | -13.6% | -30.6% | -3.8% | -5205.8% | -1763.6% | -317.3% |
| ROIC | — | -71.4% | -24.4% | -2.4% | — | -24.0% | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is CIRCLE8 Group stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 3311% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does CIRCLE8 Group pay a dividend?
Not currently.
Is CIRCLE8 Group a good stock to buy?
We do not give buy or sell advice. CIRCLE8 Group scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.